Ob/Gyn Articles

Ob/Gyn

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Christiansen M et al. – Placental growth hormone (PGH) is synthesised by the placenta, and its function is modulated by growth hormone binding protein (GHBP). The potential of PGH and GHBP as maternal serum screening markers for Down syndrome (DS) was examined. PHG and GHBP are early first trimester maternal serum markers for DS.

Related Articles

Catastrophic antiphospholipid syndrome in a patient with Down syndrome
Lupus, 10/05/09    Relevance Score: 69%

Ethnic differences in considerations whether or not to participate in prenatal screening for Down syndrome
Prenatal Diagnosis, 10/21/09    Relevance Score: 68%

Ductus venosus pulsatility index as an antenatal screening marker for Down's syndrome: use with the Combined and Integrated tests
Journal of Medical Screening, 10/07/09    Relevance Score: 68%

First-trimester Down syndrome screening in women younger than 35 years old and cost-effectiveness analysis in Taiwan population
Journal of Evaluation in Clinical Practice, 10/07/09    Relevance Score: 68%

Prenatal Screening for Down Syndrome in Australia
Ultrasound, 10/21/09    Relevance Score: 67%

Today in Repro Endo - Infertility...keeping you current

Higher interleukin-18 and mannose-binding lectin are present in uterine lumen of patients with unexplained infertility
Reproductive BioMedicine Online, 11/25/09

How common is polycystic ovary syndrome in recurrent miscarriage
Reproductive BioMedicine Online, 11/24/09

Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment
Reproductive BioMedicine Online, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address